U.S. SECURITIES AND EXCHANGE COMMISSION
                               Washington, D.C. 20549

                                   Form 10-QSB
(Mark One)

[x]  Quarterly Report under Section 13 or 15(d) of the Securities
     Exchange Act of 1934

     For the quarterly period ended September 30, 2002
--------------------------------------------------------------------------

[ ]  Transition Report under Section 13 or 15(d)of the Exchange Act For the
     Transition Period from ________  to  ___________
--------------------------------------------------------------------------
                     Commission File Number: 000-30646
--------------------------------------------------------------------------

                           CIRO INTERNATIONAL, INC.
              ----------------------------------------------
              (Name of small business issuer in its charter)

             Nevada                                13-3963499
  -------------------------------   ---------------------------------------
  (State or other jurisdiction of   (I.R.S. Employer Identification Number)
  incorporation or organization)

   445 Fifth Avenue - Suite 11A, New York, New York       10016
   ------------------------------------------------   --------------
    (Address of principal executive offices)           (zip code)

             Issuers telephone number:   (212) 481-1322
                                         ----------------

Check whether the issuer (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act of 1934 during the past 12
months (or such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing
requirements for the past 90 days.

                                          Yes [ ]     No [X]

               APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
                    PROCEEDING DURING THE PRECEDING FIVE YEARS

Check whether the Registrant filed all documents and reports
required to be filed by Section 12, 13 or 15(d) of the Exchange Act
after the distribution of securities under a plan confirmed by a court.

                                         Yes [ ]     No [ ]

                APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each of the issuer's classes of
common equity, as of the latest practicable date.

Class Outstanding at September 30, 2002 Common Stock, 7,280,000

Traditional Small Business Disclosure Format (check one)

                                           Yes [ ] No [X]

                                    1

<PAGE>



ITEM 1 FINANCIAL STATEMENTS



<TABLE>
<CAPTION>

Description                                                        Page No.
<S>                                                                <C>
FINANCIAL INFORMATION:

Financial Statements

Consolidated Balance Sheets at September 30, 2002
   (Unaudited) and December 31, 2001............................   3

Consolidated Statements of Operations for the Quarters and
   Nine Months Ended September 30, 2002 and 2001
   (Unaudited)..................................................   4

Consolidated Statements of Cash Flows for the Nine Months Ended
   September 30, 2002 and September 30, 2001 (Unaudited)........   5

Notes to Consolidated Financial Statements (Unaudited)..........   6-7

</TABLE>

                                       2

<PAGE>


                   CIRO INTERNATIONAL, INC. AND SUBSIDIARY
                         CONSOLIDATED BALANCE SHEETS
                   ---------------------------------------
                                  (Unaudited)

                                 - ASSETS -


<TABLE>
<CAPTION>

CONSOLIDATED BALANCE SHEETS
                                 - ASSETS -


                                                    September 30,  December 31,
                                                        2002           2001
                                                    -------------  ------------
<S>                                                 <C>            <C>
CURRENT ASSETS:
 Cash                                               $         127  $        211
 Accounts receivable                                        4,725             -
                                                    -------------  ------------
TOTAL CURRENT ASSETS                                        4,852           211
                                                    -------------  ------------

TOTAL ASSETS                                        $       4,852  $        211
                                                    =============  ============

                   - LIABILITIES AND SHAREHOLDERS' EQUITY -

CURRENT LIABILITIES:
 Accounts payable and accrued expenses              $      10,000  $     10,000
                                                    -------------  ------------
TOTAL CURRENT LIABILITIES                                  10,000        10,000
                                                    -------------  ------------

SHAREHOLDER=S EQUITY (DEFICIT)
 Common  stock  -  $.001  par value, 50,000,000
  shares authorized, 7,280,000 shares issued and
  outstanding for each period                               7,280         7,280
Additional paid-in capital                                944,069       924,769
 Accumulated deficit                                     (956,497)     (941,838)
                                                    -------------  ------------

                                                           (5,148)       (9,789)
                                                    -------------  ------------

TOTAL LIABILITIES AND SHAREHOLDERS EQUITY (DEFICIT) $       4,852  $        211
                                                    -------------  ------------

</TABLE>

  The accompanying notes are an integral part of these consolidated financial
                                  statements.

                                       3

<PAGE>


                    CIRO INTERNATIONAL, INC. AND SUBSIDIARY
                     CONSOLIDATED STATEMENTS OF OPERATIONS
                    ---------------------------------------
                                  (Unaudited)

<TABLE>
<CAPTION>

CONSOLIDATED STATEMENTS OF OPERATIONS

                                    For the Three Months  For the Nine Months
                                     Ended September 30    Ended September 30
                                    --------------------  --------------------
                                       2002       2001       2002       2001
                                    ---------  ---------  ---------  ---------
<S>                                 <C>        <C>        <C>        <C>
REVENUES:
 Royalty income                     $   2,025  $       -  $   8,238  $  11,378
                                    ---------  ---------  ---------  ---------

TOTAL REVENUES                          2,025          -      8,238     11,378

OPERATING COSTS:
 Selling, general and administrative
  expenses                              6,957      6,063     22,897     20,404
                                    ---------  ---------  ---------  ---------

(LOSS) BEFORE PROVISION FOR
 INCOME TAXES                          (4,932)    (6,063)   (14,659)    (9,026)

 Provision for income taxes                 -          -          -          -
                                    ---------  ---------  ---------  ---------

NET (LOSS)                          $  (4,932) $  (6,063) $ (14,659) $  (9,026)
                                    =========  =========  =========  =========

EARNINGS (LOSS) PER SHARE

 Basic                              $       -  $       -  $       -  $       -
                                    =========  =========  =========  =========

 Diluted                            $       -  $       -  $       -  $       -
                                    =========  =========  =========  =========

 Weighted average number of common
  shares Outstanding - basic
  and diluted                       7,280,000  7,280,000  7,280,000  7,280,000
                                    =========  =========  =========  =========

</TABLE>

                                      4

<PAGE>


                    CIRO INTERNATIONAL, INC. AND SUBSIDIARY
                     CONSOLIDATED STATEMENTS OF CASH FLOWS
                    ---------------------------------------
                                   (Unaudited)

<TABLE>
<CAPTION>

CONSOLIDATED STATEMENTS OF CASH FLOWS
                                                     For the Nine Months Ended
                                                          September 30
                                                     -------------------------
                                                         2002         2001
                                                     -----------  ------------
<S>                                                  <C>          <C>
INCREASE (DECREASE) IN CASH:

CASH FLOWS FROM OPERATING ACTIVITIES:
 Net (loss)                                          $   (14,659) $     (9,026)
 Adjustments to reconcile net (loss) to net cash
  (used) by operating activities:
   Management fees credited to additional
    paid-in capital                                       18,000         7,000
 Decrease in assets:
   Accounts receivable                                    (4,725)            -
                                                     -----------  ------------
    Net cash (used) by operating activities               (1,384)       (2,026)
                                                     -----------  ------------

CASH FLOWS FROM FINANCING ACTIVITIES:
 Capital contributed                                       1,300             -
                                                     -----------  ------------
    NET CASH PROVIDED BY FINANCING ACTIVITIES              1,300             -
                                                     -----------  ------------

NET (DECREASE) IN CASH                                       (84)       (2,026)

 Cash, at beginning of year                                  211         2,235
                                                     -----------  ------------

CASH, AT END OF PERIOD                               $       127  $        209
                                                     ===========  ============
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
 Cash paid during the year for:
   Income taxes                                      $       755  $        700
   Interest                                          $         -  $          -

</TABLE>

                                       5

<PAGE>


                    CIRO INTERNATIONAL, INC. AND SUBSIDIARY
                  NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                  ------------------------------------------
                                  (UNAUDITED)

NOTE   1   -NATURE OF BUSINESS:

           On November 12,  1997,  Mid-Way  Medical and Diagnostic Center, Inc.
           ("Mid-Way  Medical")  a Florida corporation,  changed  its  domicile
           state to Nevada and changed  its  name  to  Ciro International, Inc.
           ("the  Company").  On  December 2, 1997, Mid-Way  Acquisition  Corp.
           ("Mid-Way"), a wholly owned  subsidiary  of  Mid-Way Medical, merged
           with Ciro Jewelry, Inc.

           At  the  closing,  Jewelry's sole shareholder was  issued  2,500,000
           shares of the Company's  stock  in  exchange for all the outstanding
           shares of the subsidiary. As a result of the merger, all the assets,
           liabilities and the business of the subsidiary  became  the  assets,
           liabilities  and  business  of Mid-Way. At the same time, the former
           majority shareholder of Mid-Way  Medical canceled and/or sold a vast
           majority  of his shares in the Company.  After  the  merger  Mid-Way
           changed  its   name  to  Ciro  Jewelry,  Inc.  This  transaction  is
           considered  to be  a  recapitalization  with  Ciro  Jewelry  as  the
           accounting acquirer and has been reflected using reverse acquisition
           accounting.

           Ciro Jewelry  Inc.  (subsidiary)  owns  a  trademark  for the "Ciro"
           jewelry  name  in the following countries: Bolivia, Chile,  Hungary,
           Israel, Japan, Macao, Mexico, Monaco, Panama, Philippines, Portugal,
           South Korea, Russia  and the United States. The Company licenses its
           trademark and receives royalties from the licensees.


NOTE   2   -GOING CONCERN UNCERTAINTY:

           The  accompanying  consolidated   financial   statements  have  been
           prepared on a going concern basis which contemplates the realization
           of assets and liquidation of liabilities in the  ordinary  course of
           business.  For  the  quarter  ended  September 30, 2002, the Company
           incurred a loss of ($4,932), which increased the accumulated deficit
           to  ($956,497). In addition the Company's  main  source  of  royalty
           income  has  paid  only  a  nominal  amount  during  2002. It is the
           Company's  intention  to  seek a replacement licensee for  its  main
           source of royalty income, however  to  date,  a  replacement has not
           been found.

           The current operating expenses of the Company are  minimal.  Royalty
           income  and  the  majority  shareholder  provided  the funds for all
           operating expenses during the nine months ended September  30, 2002.
           Operating  expenses  primarily  consist  of  management  fees  to an
           affiliate and other nominal costs. The shareholder has indicated his
           willingness   to   provide   the  necessary  working  capital  until
           sufficient royalty income is generated  from its trademark, or other
           financing is obtained to make the Company self sufficient.

           In view of these matters, realization of  the  assets of the Company
           is dependent upon the Company's ability to generate  royalty  income
           from  its  trademark,  and the success of its future operations. The
           financial statements do  not  include  adjustments  relating  to the
           recoverability  and  classification  of  recorded  asset amounts and
           classification  of  liabilities that might be necessary  should  the
           Company be unable to continue in existence. The Company will attempt
           to market the trademark to other sources, although management cannot
           provide assurance that they will be successful in doing so.


                                       6

<PAGE>


                    CIRO INTERNATIONAL, INC. AND SUBSIDIARY
                  NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                  ------------------------------------------
                                  (UNAUDITED)

NOTE   3   -RELATED PARTY TRANSACTIONS

           During the quarter ended  September  30,  2002, the Company incurred
           management fees of $6,000 with an affiliate.   The management fee is
           for rent and other administrative charges.  No management  fees were
           paid  during  the  quarter ended September 30, 2002, the balance  of
           $6,000 has been forgiven and is included as part of additional paid-
           in capital.


NOTE   4   -SUBSEQUENT EVENTS

           Pursuant to a February 13, 2003 letter agreement, in connection with
           a proposed exchange  of  the  Company's  common stock for all of the
           outstanding capital stock of Advanced Bio/Chem,  Inc.,  the  Company
           has agreed to:

           (a)Sell approximately 5,220,000 common shares for $60,000. The funds
              for  these  shares were received in April of 2003, but the shares
              have not yet been issued.

           (b)Effectuate a  one-for-3.5 reverse stock split with respect to its
              issued  and  outstanding  common  shares,  leaving  approximately
              3,600,000 common shares outstanding.

           (c)Exchange 6,150,000 newly issued common shares (approximately 63%)
              for all of the  capital  stock  of  Advanced  Bio/Chem, Inc. This
              transaction  will  be  accounted  for  using reverse  acquisition
              accounting.  The anticipated transactions  should be completed in
              June 2003.

              This  exchange  will  limit  future  years'  utilization  of  the
              Company's net operating losses.

           On April 21, 2003, the Company and Advanced Bio/Chem,  Inc.  ("ABC")
           entered  into  an Agreement and Plan of Merger whereby the a wholly-
           owned subsidiary  of  the  Company,  Alpha Bravo/Charlie Acquisition
           Corp. ("ABC Acquisition Corp."), will  merge  with and into ABC in a
           tax free exchange of shares at which time ABC will be a wholly owned
           subsidiary  of  the  Company  ("Merger").  At  the  same   time  the
           shareholders of ABC will receive shares of the Company on a one-for-
           one  basis  in exchange for their shares in ABC. As a result of  the
           Merger, the shareholders  of  ABC will hold approximately 65% of the
           issued and outstanding Common Stock  of  the Company and the Company
           will own 100% of the issued and outstanding  Common Stock of ABC. At
           the closing of the Merger, the present officer  and  director of the
           Company  will  resign, the present officers of ABC will  remain  the
           management team  of  ABC  and  certain  of  those  employees will be
           officers  of  the  Company.  Further, the Company's new  board  will
           consist of persons nominated by the shareholders of ABC prior to the
           Merger.

                                       7

<PAGE>


ITEM 2
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATION

RESULTS OF OPERATIONS


The Company had royalty revenues for the quarter and nine months ended
September 30, 2002 of $2,025 and $8,238 as compared to royalty revenues of nil
and $11,378 for the same periods of 2001.  The decrease in royalty income over
the nine month period was caused by decreased sales by its remaining licensees.
The Company is currently attempting to market its trademark to other sources,
although management cannot provide assurance that they will be successful in
doing this.

Selling, general and administrative expenses ("SG&A") were $6,957 and $22,897
for the third quarter and first nine months of 2002 compared to $6,063 and
$20,404 for the same periods of 2001.

The Company had net losses of $4,932 and net losses of $14,659 for the third
quarter and the first nine months of 2002 as compared to net losses of $6,063
and $9,026 for the same periods of 2001.

LIQUIDITY AND CAPITAL RESOURCES

The Company had a working capital deficiency at September 30, 2002 of $5,148
compared to working capital deficiency of $9,789 as of December 31, 2001.  The
difference was caused by increased accounts receivable. The majority
shareholder has indicated his willingness to provide the funds for all expenses
not covered by cash flow at least through September 30, 2002. The Company is
actively attempting to add additional licensees in an attempt to generate
sufficient cash flow as to not have to rely on working capital loans from the
majority shareholder.

CAUTIONARY STATEMENT FOR PURPOSES OF THE "SAFE HARBOR" PROVISIONS OF THE
PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

It should be noted that in this Management's Discussion and Analysis or Plan of
Operations contains "forward-looking statements" within the meaning of  Section
27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended, and are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995. The
terms "believe", "anticipate", "intend", "goal", "expect" and similar
expressions may identify forward-looking statements. These forward-looking
statements represent the Company's current expectations or beliefs concerning
future events. The matters covered by these statements are subject to certain
risks and uncertainties that could cause actual results to differ materially
from those set forth in the forward-looking statements, including the Company's
dependence on weather-related factors, introduction and customer acceptance of
new products, the impact of competition and price erosion, as well as supply
and manufacturing constraints and other risks and uncertainties. The foregoing

                                       8

<PAGE>


list should not be construed as exhaustive, and the Company disclaims any
obligation to subsequently revise any forward-looking statements to reflect
events or circumstances after the date of such statements, or to reflect the
occurrence of anticipated or unanticipated events. The Company wishes to
caution readers not to place undue reliance on any such forward-looking
statements, which speak only as of the date made.


RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

In July 2001, the Financial Accounting Standards Board (FASB) issued SFAS No.
141, "Business Combinations," and SFAS No. 142, "Goodwill and Other Intangible
Assets."  SFAS No. 141 revises the guidance for business combinations,
eliminates the pooling method and is effective for business combinations
occurring after June 15, 2001.  SFAS No. 142 eliminates the amortization
requirement for goodwill and certain other intangible assets and requires that
such assets be reviewed periodically for impairment.  SFAS No. 142 is effective
for fiscal years beginning after December 15, 2001.  Neither of these standards
is anticipated to have a material impact on the Company's financial position or
results of operations.

In August 2001, the FASB issued SFAS No. 143, "Accounting for Asset Retirement
Obligations," which addresses financial accounting and reporting for
obligations associated with the retirement of tangible long-lived assets and
their associated retirement costs.  The standard applies to legal obligations
associated with the retirement of long-lived assets that result from the
acquisition, construction, development and (or) normal use of the asset.  This
standard is effective for fiscal years beginning after June 15, 2002.  This
standard is not anticipated to have a material impact on the Company's
financial position or results of operations.

In October 2001, the FASB issued SFAS No. 144, "Accounting for Impairment or
Disposal of Long-Lived Assets."  SFAS No. 144 addresses financial accounting
and reporting for the impairment or disposal of long-lived assets.  This
statement also extends the reporting requirements to report separately, as
discontinued operations, components of an entity that have either been disposed
of or are classified as held-for-sale.  SFAS No. 144 is effective for fiscal
years beginning after December 15, 2001.  This standard is not anticipated to
have a material impact on the Company's financial position or results of
operations.

In June 2002, the FASB issued Statement of Financial Accounting Standards No.
146, Accounting for Costs Associated with Exit or Disposal Activities (SFAS
146). SFAS 146 requires that a liability for a cost associated with an exit of
disposal activity be recognized when the liability is incurred. SFAS 146
requires that the initial measurement of a liability be at fair value. The
Company plans to adopt SFAS 146 effective January 1, 2003 and does not expect
that the adoption will have a material impact on its consolidated results of
operations and financial position.


                                      9

<PAGE>

In January 2003, the FASB issued Statement  of  Financial  Accounting Standards
No.  148, Accounting for Stock-Based Compensation- Transition  and  Disclosure,
which  amends  FASB Statement No. 123, Accounting for Stock-Based Compensation.
In response to a  growing  number  of  companies  announcing  plans  to  record
expenses   for  the  fair  value  of  stock  options,  Statement  148  provides
alternative  methods  of  transition  for  a voluntary change to the fair value
based method of accounting for stock-based employee  compensation. In addition,
SFAS  148  amends  the  disclosure  requirements of SFAS 123  to  require  more
prominent  and more frequent disclosures  in  financial  statements  about  the
effects of stock-based compensation.  The Company does not expect that adoption
of SFAS 148  will  have  a  material  impact  on  its  consolidated  results of
operations and financial position.


ITEM 3

CONTROLS AND PROCEDURES

Within the 90-day period prior to the filing date of this report, an evaluation
was conducted under the supervision of and with the participation of the
Company's management, including the Chief Executive Officer and the Chief
Financial Officer, of the effectiveness of the design and operation of the
Company's disclosure controls and procedures. Based on that evaluation, the
Chief Executive Officer and the Chief Financial Officer have concluded that our
disclosure controls and procedures are effective to ensure that all material
information related to the Company and its consolidated subsidiaries is made
known to them, particularly during the period when our periodic reports are
being prepared. Subsequent to the date the Chief Executive Officer and Chief
Financial Officer completed their evaluation, there have been no significant
changes in the Company's internal controls, or in other factors that could
significantly affect the internal controls, including any corrective actions
with regard to significant deficiencies and material weaknesses. It should be
noted that the design of any system of controls is based in part upon certain
assumptions about the likelihood of future events, and there can be no
assurance that any design will succeed in achieving its stated goals under all
potential future conditions, regardless of how remote.


                                    PART II


ITEM 1. LEGAL PROCEEDINGS

None.

ITEM 2. CHANGES IN SECURITIES

None

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None

                                       10
<PAGE>

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

None


ITEM 5. OTHER INFORMATION


None


ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K


a. Exhibit Index

Exhibit 99.1 - Certification of President and Principal Financial Officer

Exhibit 99.2 - Certification of President and Principal Financial Officer

b. Reports on Form 8-K


None.


                                  SIGNATURES


In accordance with the requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned, thereunto duly
authorized.


CIRO INTERNATIONAL, INC.


/s/ Murray Wilson
-------------------
Name: Murray Wilson
Title: President, Chief Financial Officer and Chairman of the Board
Date:  June 11, 2003



                                      11

<PAGE>


EXHIBIT 99.1

                          CERTIFICATION OF PRESIDENT
                        AND PRINCIPAL FINANCIAL OFFICER


I, Murray Wilson, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of Ciro International,
Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4. I am responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the
registrant and have:

      a) designed such disclosure controls and procedures to ensure that
      material information relating to the registrant, including its
      consolidated subsidiaries, is made known to us by others within
      those entities, particularly during the period in which this
      quarterly report is being prepared;

      b) evaluated the effectiveness of the registrant's disclosure
      controls and procedures as of a date within 90 days prior to the
      filing date of this quarterly report (the "Evaluation Date"); and

      c) presented in this quarterly report my conclusions about the
      effectiveness of the disclosure controls and procedures based on
      our evaluation as of the Evaluation Date;

5. I have disclosed, based on our most recent evaluation, to the registrant's
auditors and the audit committee of registrant's board of directors (or persons
performing the equivalent functions):

      a) all significant deficiencies in the design or operation of
      internal controls which could adversely affect the registrant's
      ability to record, process, summarize and report financial data and
      have identified for the registrant's auditors any material
      weaknesses in internal controls; and

      b) any fraud, whether or not material, that involves management or
      other employees who have a significant role in the registrant's
      internal controls; and

<PAGE>



6. I have indicated in this quarterly report whether or not there were
significant changes in internal controls or in other factors that could
significantly affect internal controls subsequent to the date of my most
recent evaluation, including any corrective actions with regard to
significant deficiencies and material weaknesses.



Date: June 11, 2003


/s/ Murray Wilson
-------------------
Name: Murray Wilson
Title: President and Chief Financial Officer




<PAGE>